Chemotherapy
Approved for: NSCLC
Afatinib Dimaleate (Gilotrif) is a FDA-approved Chemotherapy for non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used: In patients with squamous NSCLC that got worse after treatment with platinum chemotherapy.
